وبلاگ بلیان

Quantitative Models in Life Science Business: From Value Creation to Business Processes (SpringerBriefs in Economics)

معرفی کتاب «Quantitative Models in Life Science Business: From Value Creation to Business Processes (SpringerBriefs in Economics)» نوشتهٔ Jung Kyu Canci (editor), Philipp Mekler (editor), Gang Mu (editor)، منتشرشده توسط نشر Springer International Publishing AG در سال 2022. این کتاب در فرمت pdf، زبان انگلیسی ارائه شده است.

This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries. Preface Acknowledgments Contents *-1pc Value Creation and Managing Intellectual Property in the Life Science Industry Value Creation, Valuation and Business Models in the Pharmaceutical Sector 1 Value Principles in the Pharmaceutical Industry 2 Value Creation in the Pharmaceutical Industry 3 `Keeping Focus': The Traditional Value Token 4 `Extending Horizons': Innovation-Integration Across the Value Chain 5 Value Protection: Intellectual Property in the Life Sciences 5.1 Patent Evaluation 6 Modelling the Patent Value as a Stochastic Process 6.1 The Patent Life Model 6.2 Viewing a Generic Case 6.3 Interferon Beta 1a: A Real-World Case 7 The Future of Value and Valuation in Pharma References Limited Commercial Licensing Strategies: A Piecewise Deterministic Differential Game 1 Limited Commercial Licenses in the Pharmaceutical Industry 1.1 Probability of Issuing a CL 2 A Differential Game of Limited Commercial Licensing 2.1 Preliminaries 2.2 Profits and Sales in Each Regime 2.3 Switching Between Stages 2.4 The Problem 3 Solving the Model 4 Perspective References Partnership Models for R&D in the Pharmaceutical Industry 1 Introduction 2 The Problem of R&D Efficiency of Pharmaceutical Companies 2.1 Eroom's Law 2.2 Analysis of R&D Costs in the Pharmaceutical Sector 2.3 Analysis of Pipeline Drugs 3 New R&D Open Innovation Models for Pharmaceutical Companies 3.1 Mergers and Acquisitions 3.2 In-licensing Agreements 3.3 Outsourcing R&D Processes from CROs 3.4 R&D Collaborations 3.5 Public-Private Partnerships 3.6 Crowdsourcing 3.7 Innovation Centers 3.8 Open Source References *-1pc Modelling Specific Business Processes in the Life Science Industry Pharma Tender Processes: Modeling Auction Outcomes 1 Introduction 2 Pharmaceutical Tendering 2.1 Pharmaceutical Tendering Mechanism in Different Countries 2.2 Effect of Pharmaceutical Tendering 3 Tendering as Auction: Scope and Concept 3.1 Tender Versus Auction 3.2 Independent Private Value Auction 3.3 First Price Sealed Auction 3.4 Number of Bidders 4 Empirical Methods for Price Auction Estimation 4.1 Bidding Price Determinants Estimation with Reduced Form Approach 4.2 Structural Estimation of Auction Models 4.3 Quantile-Based Non-parametric Estimation of Private Value 5 Non-parametric Estimation on Observational Data 5.1 Dataset 5.2 Visualization and Descriptive Analysis 5.3 Assumptions Validation 5.4 Modeling and Estimation 5.5 Adjustments and Lessons Learned References Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning 1 Introduction 2 Challenges of Multi-Echelon Inventory Management from an Optimization Perspective 3 Literature Review of Inventory Management 4 Reinforcement Learning for Inventory Management 4.1 Markov (Decision) Processes 5 Introduction to Reinforcement Learning 5.1 Value-Based Methods 5.2 Policy-Based Methods 5.3 Actor-Critic Methods 6 Evaluation 7 Discussion of Results 8 Outlook 9 Conclusions 10 Acronyms References *-1pc Specialized Quantitative Tools in the Life Science Industry An Invitation to Stochastic Differential Equations in Healthcare 1 Introduction 1.1 Brownian Motions 1.2 Ito's Integral and Solutions of Geometric Brownian Motions (GBM) 1.3 Existence of Solutions of Stochastic Differential Equations 2 Numerical Methods for SDEs 2.1 Euler–Maruyama Method 2.2 –Maruyama Methods 2.3 Stochastic Runge–Kutta Methods 3 A Numerical Evidence on PK/PD Models References Life Events that Cascade: An Excursion into DALY Computations 1 Introduction 2 The Hawkes–Cox Framework 2.1 The Choice of Kernel and the Rôle of δ 3 Dynkin's Formula 4 Theoretical Moments 4.1 The Moments of Counts in an Interval 4.2 The Covariance 5 Learning and Optimization 6 Synthetic Experiments 6.1 Calibration 7 Disability Adjusted Life Years 8 Concluding Remarks References
دانلود کتاب Quantitative Models in Life Science Business: From Value Creation to Business Processes (SpringerBriefs in Economics)